SCI's 6th Annual Risk Transfer & Synthetics Seminar

27 April 2022, New York (In-Person Event)

New York

27 April 2022

25+ Speakers

Leading figures in the Risk Transfer & Synthetics Sector

200 Seats

Register to secure yours today


We are excited to announce the 6th Annual Risk Transfer & Synthetics Seminar will take place as a physical event in April 2022. We will return to New York with Covid safety measures in place and featuring the same informative and engaging content you’ve grown to expect from SCI, we hope you will join us this April for another must attend event.


The North American synthetic securitisation market continues to develop, as banks seek to improve their profitability and expand their balance sheets. SCI’s Risk Transfer & Synthetics Seminar examines CRT trends and activity across the region, as well as prospects for growth and innovation. The event also showcases the mortgage insurance-linked note and GSE credit risk transfer sectors.

Registration is now open

Cost per Delegate:

Non Subscriber Subscriber Rate
Super Early Bird – December £1,190 £1,050
Early Bird – February £1,260£1,120
Full Price – March £1,400 £1,190

To get your subscriber rate please contact for your discount code.

Silver Sponsor


  • 27 April 2022
    This panel focuses on recent trends and activity in the North American synthetic securitization market. To what extent are banks turning to risk transfer technology to improve profitability and expand their balance sheets, or was the regulatory regime already driving such activity? What is likely to promote activity among US banks in 2022 and beyond?
    This panel explores how the amended GSE capital rules are impacting credit risk transfer transactions. It also covers the latest developments in the mortgage insurance-linked notes sector. What is the outlook in terms of issuance volumes and structural innovation?
    This panel provides an overview of the North American regulatory framework for risk transfer transactions. What developments have occurred with North American bank regulators over the past year? What impact is the new Democratic administration having on the market, given its focus on fairness and inclusion? What are the main differences between the North American and European regimes, and are there any structural features that are treated differently?
    This panel examines the prospects for both incumbent issuers and new entrants to the North American CRT market, including Canadian banks and US regional banks. What are the motivations and obstacles involved when considering whether to execute a CRT? Are there fewer regulatory hurdles to overcome, following Texas Capital’s ground-breaking deal?
    This panel discusses how the investor base for CRTs is evolving, in light of the continued hunt for yield and robust performance, as well as barriers to entry. It also highlights where investors see relative value and opportunities currently. How is rising inflation likely to affect investor appetite for synthetic securitisations?
    Kaelyn Abrell, ArrowMark Partners
    This panel tracks the emergence of new asset classes and jurisdictions, as well as structural innovations onto the capital relief trades scene. What role can insurance companies play in the CRT market as buyers of credit risk?